Adicet Bio, Inc. (ACET) Form 10-Q Quarterly Reports
Adicet Bio, Inc. (ACET) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ACET
CIK: 1720580
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/26
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerMark Valentine
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-28 | 2026-09-28 | 8-K | 0001720580-26-000060 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-08 | 8-K | 0001720580-26-000056 | View SEC Doc Filr Page |
| 8-K | 2026-09-01 | 2026-09-01 | 8-K | 0001720580-26-000054 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001231919-26-000916 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | 4 | 0001776004-26-000003 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001720580-26-000050 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001720580-26-000049 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-19 | 4 | 0001340875-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-19 | 4 | 0001886986-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-21 | 4 | 0001265123-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-21 | 4 | 0001610876-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-21 | 4 | 0001757601-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-21 | 4 | 0001762451-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-21 | 4 | 0001983850-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-21 | 4 | 0001776004-26-000001 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-17 | 8-K | 0001720580-26-000043 | View SEC Doc Filr Page |
| 10-K/A | 2026-05-20 | 2025-12-31 | 10-K/A | 0001720580-26-000042 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000919574-26-003239 | View SEC Doc Filr Page |
| S-8 POS | 2026-05-13 | — | S-8 POS | 0001720580-26-000038 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001720580-26-000037 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-13 | 8-K | 0001720580-26-000036 | View SEC Doc Filr Page |
| 4 | 2026-04-29 | 2026-04-27 | 4 Filing | 0001231919-26-000425 | View SEC Doc Filr Page |
| ARS | 2026-04-29 | 2025-12-31 | ARS | 0001720580-26-000029 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-29 | — | DEFA14A | 0001720580-26-000028 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-29 | 2026-04-29 | DEF 14A | 0001720580-26-000027 | View SEC Doc Filr Page |